Prophylactic octreotide for pancreatoduodenectomy: more harm than good?

No abstract is available for this paper.

• Publication year

  2014

• Venue

  HPB

• Publication date

  2014-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/hpb.12314PMID 25041506PMCID PMC4238863
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical evaluation of somatostatin use in pancreatic resections: Clinical efficacy or limited benefit?

  2013cited by this paper
• Somatostatin analogues for pancreatic surgery.

  2013cited by this paper
• A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy.

  2013cited by this paper
• A Multi-Institutional External Validation of the Fistula Risk Score for Pancreatoduodenectomy

  2013cited by this paper
• A prospective study of prophylactic long-acting octreotide in high-risk patients undergoing pancreaticoduodenectomy.

  2011cited by this paper
• A Root-Cause Analysis of Mortality Following Major Pancreatectomy

  2011cited by this paper
• Quantitative weighting of postoperative complications based on the accordion severity grading system: demonstration of potential impact using the american college of surgeons national surgical quality improvement program.

  2010cited by this paper
• Risk Prediction for Development of Pancreatic Fistula Using the ISGPF Classification Scheme

  2008cited by this paper
• Prophylactic octreotide and delayed gastric emptying after pancreaticoduodenectomy: results of a prospective randomized double-blinded placebo-controlled trial.

  2008cited by this paper
• Selective administration of prophylactic octreotide during pancreaticoduodenectomy: a clinical and cost-benefit analysis in low- and high-risk glands.

  2007cited by this paper
• Clinical and Economic Validation of the International Study Group of Pancreatic Fistula (ISGPF) Classification Scheme

  2007cited by this paper
• Somatostatin analogues in the prevention of pancreas-related complications after pancreatic resection.

  2006cited by this paper
• Postoperative pancreatic fistulas are not equivalent after proximal, distal, and central pancreatectomy

  2006cited by this paper
• Postoperative pancreatic fistula: an international study group (ISGPF) definition.

  2005cited by this paper
• Prospectively Randomized Trial Using Perioperative Low-dose Octreotide to Prevent Organ-related and General Complications after Pancreatic Surgery and Pancreatico-jejunostomy

  2005cited by this paper
• Somatostatin and its analogues in peptic ulcer bleeding: facts and pathophysiological aspects.

  2005cited by this paper
• Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective, multicenter randomized controlled trial.

  2004cited by this paper
• The effect of hyperbaric oxygen therapy on the adverse effects of octreotide on wound healing

  2004cited by this paper
• Pancreatic Fistula Rate after Pancreatic Resection

  2004cited by this paper
• The potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: a prospective, multicenter, double-blinded, randomized, placebo-controlled trial.

  2003cited by this paper
• Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding.

  2001cited by this paper
• Randomized controlled multicentre trial of somatostatin infusion after pancreaticoduodenectomy

  2001cited by this paper
• Does Prophylactic Octreotide Decrease the Rates of Pancreatic Fistula and Other Complications After Pancreaticoduodenectomy?: Results of a Prospective Randomized Placebo-Controlled Trial

  2000cited by this paper
• Does prophylactic octreotide benefit patients undergoing elective pancreatic resection?

  1999cited by this paper
• Long‐term haemodynamic effects of octreotide on postprandial splanchnic hyperemia in humans: a placebo‐controlled echo–doppler study

  1999cited by this paper
• The adverse effects of octreotide on wound healing in rats.

  1997cited by this paper
• Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease.

  1997cited by this paper
• Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis

  1996cited by this paper
• Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial.

  1995cited by this paper
• Fluctuations in the secretion of pancreatic enzymes between consecutive doses of octreotide: implications for the management of fistulae.

  1995cited by this paper
• Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis

  1995cited by this paper
• Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects.

  1994cited by this paper
• Efficacy of octreotide in the prevention of complications of elective pancreatic surgery

  1994cited by this paper
• Efficacy of octreotide in the prevention of complications of elective pancreatic surgery

  1994cited by this paper
• Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Italian Study Group [see comments]

  1994cited by this paper
• Pharmacodynamic effects of Sandostatin in the gastrointestinal tract.

  1993cited by this paper
• Role of octreotide in the prevention of postoperative complications following pancreatic resection.

  1992influential reference
• The use of somatostatin in acute pancreatitis--results of a multicenter trial.

  1990cited by this paper
• Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding.

  1990cited by this paper
• Intravenous and subcutaneous administration of a long‐acting somatostatin analogue: effects on glucose metabolism and splanchnic haemodynamics in healthy subjects

  1989cited by this paper
• Octreotide, a new somatostatin analogue.

  1989cited by this paper
• Somatostatin in the treatment of acute pancreatitis: a prospective randomised controlled trial.

  1989cited by this paper
• Role of epidermal growth factor in healing of chronic gastroduodenal ulcers in rats.

  1988cited by this paper
• A microsphere study on the effects of somatostatin and secretin on regional blood flow in anesthetized dogs.

  1982cited by this paper
• Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.

  1981cited by this paper
• Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects.

  1981cited by this paper
• Effect of somatostatin on regional splanchnic blood flows in man. Angiographic studies.

  1980cited by this paper
• [Prevention of postoperative pancreatic complications following duodenopancreatectomy using somatostatin].

  1979cited by this paper
• Somatostatin suppresses secretin and pancreatic exocrine secretion

  1975cited by this paper

• Pancreatic ductal adenocarcinoma and pancreatic surgery in the 21st century: triumphs, turning points, and unresolved challenges.

  2026cites this paper
• "Somatostatin analogues do not reduce the risk of clinically relevant post-operative fistula rates in patients undergoing pancreatic surgery", a systematic review and meta-analysis.

  2025cites this paper
• Somatostatin Analogs for Preventing Postoperative Pancreatic Fistula: Past Evidence Reveals New Opportunities

  2025cites this paper
• A risk-adjusted evaluation of the impact of neoadjuvant therapy on pancreatic fistula development after pancreatoduodenectomy.

  2025cites this paper
• Surgical techniques for modular one-stage emergent pancreaticoduodenectomy for blunt abdominal trauma: experiences from three centres and a review of the literature

  2025cites this paper
• Prophylactic somatostatin analogs for postoperative pancreatic fistulas: a cross-sectional survey of AHPBA surgeons.

  2024cites this paper
• Contemporary Outcomes of Grade-C Postoperative Pancreatic Fistula in a Nationwide Database.

  2024cites this paper
• Extending Quality Improvement for Pancreatoduodenectomy Within the High-Volume Setting

  2023cites this paper
• Non-Surgical Interventions for the Prevention of Clinically Relevant Postoperative Pancreatic Fistula—A Narrative Review

  2023cites this paper
• Polyethylene glycol-coated haemostatic patch for prevention of clinically relevant postoperative pancreatic fistula after pancreatoduodenectomy: randomized clinical trial

  2023cites this paper
• Effect of postoperative utilization of somatostatin on clinical outcome after definitive surgery for duodenal fistula

  2023cites this paper
• Early vs late drain removal after pancreatic resection—a systematic review and meta-analysis

  2023cites this paper
• Impact of spleen preservation on the incidence of postoperative pancreatic fistula after distal pancreatectomy: Is less more?

  2022cites this paper
• Prophylactic octreotide for postoperative pancreatic fistula in patients with pancreatoduodenectomy

  2022cites this paper
• "Mitigation strategies for post-operative pancreatic fistula after pancreaticoduodenectomy in high-risk pancreas: an evidence-based algorithmic approach"-a narrative review.

  2022cites this paper
• Somatostatin analogues for the prevention of pancreatic fistula after open pancreatoduodenectomy: A nationwide analysis.

  2022cites this paper
• Development and external validation of DISPAIR fistula risk score for clinically relevant postoperative pancreatic fistula risk after distal pancreatectomy

  2022cites this paper
• Risk Factors and Clinical Impacts of Post-Pancreatectomy Acute Pancreatitis After Pancreaticoduodenectomy: A Single-Center Retrospective Analysis of 298 Patients Based on the ISGPS Definition and Grading System

  2022cites this paper
• SSAT GI Surgery Debate: Hepatobiliary and Pancreas: Is Post-Pancreatectomy Acute Pancreatitis a Relevant Clinical Entity?

  2021cites this paper
• Complications After Pancreatic Surgery

  2021cites this paper
• Decision points in pancreatoduodenectomy: Insights from the contemporary experts on prevention, mitigation, and management of postoperative pancreatic fistula.

  2021cites this paper
• Central Pancreatectomy: Significance of Vascularity on Anastomotic Integrity and a Note on Reconstructive Technique

  2021cites this paper
• The Fistula Risk Score Catalog

  2020cites this paper
• Pasireotide and Corticosteroids for Prevention of Pancreatic Fistula-Over-HYPed?

  2020cites this paper
• The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors

  2020cites this paper
• Risk factors and preventive measures for postoperative pancreatic fistula after pancreaticoduodenectomy

  2020cites this paper
• Surgeon experience contributes to improved outcomes in pancreatoduodenectomies at high risk for fistula development.

  2020cites this paper
• Somatostatin administration following pancreatoduodenectomy: a case-matched comparison according to surgical technique, body mass index, American Society of Anesthesiologists’ score and Fistula Risk Score

  2020cites this paper
• The Landmark Series: Mitigation of the Postoperative Pancreatic Fistula

  2020cites this paper
• The Influence of Intraoperative Blood Loss on Fistula Development Following Pancreatoduodenectomy

  2020cites this paper
• Efficacy of Pasireotide for Prevention of Postoperative Pancreatic Fistula in Pancreatic Surgery: a Systematic Review and Meta-analysis

  2020cites this paper
• Predictive Factors of Pancreatic Fistula After Pancreaticoduodenectomy and External Validation of Predictive Scores

  2019cites this paper
• Response to Comment on “Characterization and Optimal Management of High-risk Pancreatic Anastomoses During Pancreatoduodenectomy Response to Goussous and Cunningham”

  2019cites this paper
• Early postoperative pancreatitis following pancreaticoduodenectomy: what is clinically relevant postoperative pancreatitis?

  2019cites this paper
• Antimicrobial Stewardship Reduces Surgical Site Infection Rate, as well as Number and Severity of Pancreatic Fistulae after Pancreatoduodenectomy

  2019cites this paper
• An updated systematic review and meta-analysis of the use of octreotide for the prevention of postoperative complications after pancreatic resection

  2019cites this paper
• Somatostatin analogues and the risk of post-operative pancreatic fistulas after pancreatic resection - A systematic review & meta-analysis.

  2019cites this paper
• Risk factors for pancreatic fistula following distal pancreatectomy: a retrospective study of 211 consecutive patients

  2019cites this paper
• The Beneficial Effects of Minimizing Blood Loss uodenectomy in Pancreatod

  2019cites this paper
• The Beneficial Effects of Minimizing Blood Loss in Pancreatoduodenectomy.

  2019cites this paper
• Prevention and Management of Complications of Pancreatic Surgery

  2019cites this paper
• The Use of  Prophylactic Somatostatin Therapy Following Pancreaticoduodenectomy: A Meta-analysis of Randomised Controlled Trials 

  2019cites this paper
• Strategies for Prevention and Treatment of Pancreatic Fistula

  2018cites this paper
• Randomized clinical trial of the effect of a fibrin sealant patch on pancreatic fistula formation after pancreatoduodenectomy

  2018cites this paper
• Efficacy of octreotide in the prevention of complications after pancreaticoduodenectomy in patients with soft pancreas and non-dilated pancreatic duct: A prospective randomized trial.

  2018cites this paper
• Response to: Managing the High-risk Pancreatic Anastomosis.

  2018cites this paper
• Taking Theory to Practice: Quality Improvement for Pancreaticoduodenectomy and Development and Integration of the Fistula Risk Score.

  2018cites this paper
• Pasireotide is not effective in reducing the development of postoperative pancreatic fistula.

  2018cites this paper
• Evolving the Paradigm of Early Drain Removal Following Pancreatoduodenectomy

  2018cites this paper
• The Role of Prophylactic Octreotide Following Pancreaticoduodenectomy to Prevent Postoperative Pancreatic Fistula: A Meta-Analysis of the Randomized Controlled Trials

  2018cites this paper
• Postoperative Management in Patients Undergoing Major Pancreatic Resections

  2018cites this paper
• Defining the practice of distal pancreatectomy around the world.

  2018cites this paper
• Don ’ t Calculate Post-hoc Power Using Observed Estimate of Effect Size A

  2018cites this paper
• Pancreas fistula risk prediction: implications for hospital costs and payments.

  2017cites this paper
• [Evidence-based supportive measures to secure pancreatic anastomoses].

  2017cites this paper
• Pasireotide for the Prevention of Pancreatic Fistula Following Pancreaticoduodenectomy: A Cost-effectiveness Analysis

  2017cites this paper
• Pancreatic anastomosis after pancreatoduodenectomy: A position statement by the International Study Group of Pancreatic Surgery (ISGPS)

  2017cites this paper
• Evidenzlage zu supportiven Maßnahmen zur Sicherung der Pankreasanastomose

  2017cites this paper
• The HIBA Index for ALPPS, Preliminary Results to Interpret With Caution.

  2017cites this paper
• PANCREATODUODENECTOMY: BRAZILIAN PRACTICE PATTERNS *

  2017cites this paper
• Prophylactic Octreotide for Pancreatectomy: Benefit or Harm? Correspondence re McMillan et al, 2016;264: 344.

  2017cites this paper
• Recent Advances in Pancreatic Cancer Surgery

  2017cites this paper
• Risk Factors and Mitigation Strategies for Pancreatic Fistula After Distal Pancreatectomy: Analysis of 2026 Resections From the International, Multi-institutional Distal Pancreatectomy Study Group

  2017cites this paper
• Pancreatogastrostomy Vs. Pancreatojejunostomy: a Risk-Stratified Analysis of 5316 Pancreatoduodenectomies

  2017cites this paper
• Pasireotide for the Prevention of Postoperative Pancreatic Fistula: Time to Curb the Enthusiasm?

  2017cites this paper
• Levels of Evidence in Medical Research: "Bigger Is Not Always Better".

  2017cites this paper
• Reply to Comment on "Teres Ligament Patch Reduces Relevant Morbidity After Distal Pancreatectomy (the DISCOVER Randomized Controlled Trial)".

  2017cites this paper
• Validation of Fistula Risk Score calculator in diverse North American HPB practices.

  2017cites this paper
• Characterization and Optimal Management of High-risk Pancreatic Anastomoses During Pancreatoduodenectomy

  2017cites this paper
• Pancreatic fistula risk for pancreatoduodenectomy: an international survey of surgeon perception.

  2017cites this paper
• The "Colonial Wig" pancreaticojejunostomy: zero leaks with a novel technique for reconstruction after pancreaticoduodenectomy.

  2017cites this paper
• Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance Evaluation

  2016cites this paper
• Risk factors and preventive strategies for post-operative pancreatic fistula after pancreatic surgery: a comprehensive review

  2016cites this paper
• Defining post-operative pancreatitis as a new pancreatic specific complication following pancreatic resection.

  2016cites this paper
• Externalized Stents for Pancreatoduodenectomy Provide Value Only in High-Risk Scenarios

  2016cites this paper
• Serum amylase and C‐reactive protein in risk stratification of pancreas‐specific complications after pancreaticoduodenectomy

  2016cites this paper
• Role of Prophylactic Octreotide in Pancreaticoduodenectomy: A Single Centre Comparative Study in 456 Whipple's Patients

  2016cites this paper
• The influence of fellowship training on the practice of pancreatoduodenectomy.

  2016cites this paper
• Advances in Surgical Management of Pancreatic Diseases.

  2016cites this paper
• Surgical Results of Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: a Multi-institutional Retrospective Study of 174 patients.

  2016cites this paper
• Calculating the risk of a pancreatic fistula after a pancreaticoduodenectomy: a systematic review.

  2015cites this paper
• Octreotide Does Not Prevent Pancreatic Fistula Following Pancreatoduodenectomy in Patients with Soft Pancreas and Non-dilated Duct: A Prospective Randomized Controlled Trial

  2015cites this paper
• The harm of prophylactic octreotide in pancreatoduodenectomy: more artefact than fact?

  2015cites this paper
• Prophylactic octreotide in pancreatoduodenectomy: response to Yang et al.

  2015cites this paper
• Defining the practice of pancreatoduodenectomy around the world.

  2015cites this paper
• Predictive factors for pancreatic fistula following pancreatectomy

  2014cites this paper
• Is it time to standardize patient factors for HPB surgery?

  2014cites this paper
• Significance of preoperative radiographic pancreatic density in predicting pancreatic fistula after surgery for pancreatic neuroendocrine tumors.

  2014cites this paper